采用无对照开放、单剂量顺序给药的研究方法评价复方盐酸替利定口服溶液的药代动力学特性
[Translation] Evaluation of the pharmacokinetic properties of compound tilidine hydrochloride oral solution by an uncontrolled open-label, single-dose sequential administration study
本试验的目的是评价四川抗菌素工业研究所有限公司和国药集团工业有限公司廊坊分公司共同研制的复方盐酸替利定口服溶液人体药代动力学特性及安全性,为临床安全、合理用药提供参考依据。
[Translation] The purpose of this study is to evaluate the pharmacokinetic characteristics and safety of the compound tilidine hydrochloride oral solution jointly developed by Sichuan Antibiotics Industrial Research Institute Co., Ltd. and Sinopharm Group Industrial Co., Ltd. Langfang Branch in humans, and to provide a reference for safe and rational clinical use of drugs.
100 Clinical Results associated with Sinopharm Group Industry Co., Ltd. Langfang Branch
0 Patents (Medical) associated with Sinopharm Group Industry Co., Ltd. Langfang Branch
100 Deals associated with Sinopharm Group Industry Co., Ltd. Langfang Branch
100 Translational Medicine associated with Sinopharm Group Industry Co., Ltd. Langfang Branch